[Hepatic protection in patients with generalized purulent peritonitis complicated by sepsis].
Plotkin
L L
LL
Bordunovskiĭ
V N
VN
Bazarova
E N
EN
Smirnov
D M
DM
D015415:Biomarkers / Q000097:blood; D005260:Female; D006025:Glycosaminoglycans / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D048550:Hepatic Insufficiency / Q000209:etiology / Q000276:immunology / Q000401:mortality / Q000517:prevention & control*; D006801:Humans; D015850:Interleukin-6 / Q000097:blood; D008099:Liver / Q000187:drug effects*; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D010538:Peritonitis / Q000150:complications* / Q000276:immunology / Q000401:mortality / Q000601:surgery; D011446:Prospective Studies; D018805:Sepsis / Q000209:etiology* / Q000276:immunology / Q000401:mortality / Q000601:surgery; D012720:Severity of Illness Index; D013997:Time Factors
D015415:Biomarkers; D006025:Glycosaminoglycans; D015850:Interleukin-6; C007858:glucuronyl glucosamine glycan sulfate